John Kaczmar to Cetuximab
This is a "connection" page, showing publications John Kaczmar has written about Cetuximab.
Connection Strength
0.193
-
Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions. JCO Oncol Pract. 2021 01; 17(1):54-56.
Score: 0.193
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.